Elyse G. Seltzer
Corporate Officer/Principal presso Yale University
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Steven Gelone | M | 56 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 10 anni |
| Dong Kim | M | 47 | 3 anni | |
| Daniel Burgess | M | 62 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 8 anni |
| Elizabeth Barrett | F | 62 | 5 anni | |
| Phil Thomson | M | - | 13 anni | |
| Emma Walmsley | F | 55 | 14 anni | |
| Ari Helenius | M | - |
Yale University
| 41 anni |
| Radha Kuppalli | F | - |
Yale University
| 16 anni |
| Richard Foster | M | 82 |
Yale University
| - |
| Lei Zhang | M | 51 |
Yale University
| - |
| Richard Levin | M | 77 |
Yale University
| 31 anni |
| Urs Rohner | M | 65 | 9 anni | |
| Jason Smith | M | 52 | 4 anni | |
| Stanley McChrystal | M | 69 |
Yale University
| - |
| Christopher di Bonaventura | M | - |
Yale University
| - |
| Melanie Ginter | F | - |
Yale University
| - |
| Alexandros Makridis | M | 62 |
Yale University
| - |
| Steven Alan Orszag | M | - |
Yale University
| - |
| Martha Woodcock | F | - |
Yale University
| - |
| Steven Dworetzky | M | - |
Yale University
| - |
| Stephen Winter | M | - |
Yale University
| - |
| Eileen Donahue | F | - |
Yale University
| - |
| Hernando José Gómez Restrepo | M | 67 |
Yale University
| - |
| Marlene Beth Schwartz | M | - |
Yale University
| - |
| Michael Warren | M | 56 |
Yale University
| - |
| Rishay Patel | M | - |
Yale University
| 3 anni |
| Steve Blum | M | 72 |
Yale University
| - |
| Daniel C. Esty | M | - |
Yale University
| - |
| Hyuk-Jeen Suh | M | - |
Yale University
| 4 anni |
| Dianne Witte | F | - |
Yale University
| - |
| Sandra A. Carson | M | 70 |
Yale University
| - |
| Louise M. Dembry | M | - |
Yale University
| 31 anni |
| Liane E Philpotts | M | - |
Yale University
| - |
| Scott Nicholas Gettinger | M | - |
Yale University
| - |
| John Puziss | M | - |
Yale University
| 23 anni |
| James Timberlake | M | - |
Yale University
| - |
| Stephen Kieran | M | - |
Yale University
| - |
| Sally E. Shaywitz | M | - |
Yale University
| - |
| John Rice | M | 57 |
Yale University
| - |
| Michael Roemer | M | 96 |
Yale University
| - |
| Denny Sakkas | M | - |
Yale University
| - |
| Bruce E. Wexler | M | - |
Yale University
| - |
| Jaime Gerber | M | - |
Yale University
| 11 anni |
| Joseph F. Renzulli | M | - |
Yale University
| - |
| Daniel Abadi | M | - |
Yale University
| - |
| Yung Chi Cheng | M | - |
Yale University
| - |
| David Nierenberg | M | 70 |
Yale University
| - |
| Robert J. Shiller | M | - |
Yale University
| - |
| Harvey J. Berger | M | 74 |
Yale University
| - |
| Mark Velleca | M | 60 |
Yale University
| - |
| John Deno Geanakoplos | M | 68 |
Yale University
| 38 anni |
| David Sze | M | 58 |
Yale University
| - |
| Jeffrey Bewkes | M | 71 |
Yale University
| - |
| Leon E. Rosenberg | M | 90 |
Yale University
| 25 anni |
| William Kennard | M | 67 |
Yale University
| 10 anni |
| Vincent Marchesi | M | 88 |
Yale University
| 51 anni |
| Henry George Jarecki | M | - |
Yale University
| - |
| Edward L. Snyder | M | 77 |
Yale University
| - |
| Alan G. Schwartz | M | 84 |
Yale University
| 37 anni |
| Joseph A. Madri | M | 80 |
Yale University
| 44 anni |
| Gerard N. Burrow | M | - |
Yale University
| - |
| William Miller | M | 67 |
Yale University
| - |
| William Wright | M | 64 |
Yale University
| - |
| Michael Jerome Hawley | M | 62 |
Yale University
| - |
| James Tananbaum | M | 60 |
Yale University
| - |
| Jeff Miller | M | 75 |
Yale University
| - |
| Joseph P. Schlessinger | M | 79 |
Yale University
| - |
| Barry J. Nalebuff | M | - |
Yale University
| - |
| Kyle Pruett | M | - |
Yale University
| - |
| Joan Dea | F | 60 |
Yale University
| - |
| Linda Mason | F | 69 |
Yale University
| - |
| Robert Schwartz | M | - |
Yale University
| 20 anni |
| Peter R. Crane | M | - |
Yale University
| - |
| Stephen L. Carter | M | - |
Yale University
| - |
| Amy Wrzesniewski | M | - |
Yale University
| - |
| Viswanathan Vinay | M | - |
Yale University
| - |
| Martin H. Schultz | M | - |
Yale University
| - |
| Jonathan R. Macey | M | 68 |
Yale University
| - |
| Kenneth V. Schwartz | M | - |
Yale University
| - |
| Vincent Pieribone | M | - |
Yale University
| - |
| Patricia Sue Fitzsimons | M | - |
Yale University
| - |
| Brad Huang | M | 59 |
Yale University
| - |
| Stephen S. Roach | M | 79 |
Yale University
| - |
| Thomas Conley | M | - |
Yale University
| - |
| Edward F. Zigler | M | - |
Yale University
| - |
| Peter Moore | M | - |
Yale University
| - |
| Thomas A. Steitz | M | - |
Yale University
| - |
| Ali K. Riba | M | - |
Yale University
| 20 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Garrett | M | 44 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | - |
| Robert L. Crotty | M | 50 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | - |
| Peter Pfreundschuh | M | 55 | 2 anni | |
| Mark Corrigan | M | 66 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 4 anni |
| Gary Sender | M | 62 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 7 anni |
| Philip Hampton | M | 70 | 4 anni | |
| Ralf Schmid | M | 57 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 10 anni |
| Mark Stejbach | M | 61 | 4 anni | |
| George Harrison Talbot | M | 76 |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | 12 anni |
| Joseph W. la Barge | M | 53 | 5 anni | |
| Gil Hakim | M | 54 | 8 anni | |
| Thomas Mount | M | - | 7 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 88 | 88.00% |
| Austria | 8 | 8.00% |
| Regno Unito | 5 | 5.00% |
| Irlanda | 5 | 5.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Elyse G. Seltzer
- Contatti personali
